RSS feed

Publications by Frank Brosstad

197 publications found

Original articles

Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L, Westen GI, Stribolt-Halvorsen PE (2022)
Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
Int J Clin Pharmacol Ther, 60 (10), 430-438
DOI 10.5414/CP204271, PubMed 35979901

Holm S, Oma I, Hagve TA, Saatvedt K, Brosstad F, Mikkelsen K, Rydningen H, Risnes I, Almdahl SM, Ueland T, Aukrust P, Halvorsen B, Hollan I (2019)
Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study
BMJ Open, 9 (5), e030651
DOI 10.1136/bmjopen-2019-030651, PubMed 31079089

Meen O, Brosstad F, Liestøl K, Kunszt G, Bendz B, Wettergreen M, Schjelderup NM, Andreassen T, Erikssen G (2012)
Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction
Scand J Clin Lab Invest, 72 (4), 318-25
DOI 10.3109/00365513.2012.666565, PubMed 22724626

Jenssen EK, Brosstad F, Pedersen T, Bjørnsen S, Jørgensen JJ, Sandbæk G (2011)
Thrombin generation and platelet activation related to subintimal percutaneous transluminal angioplasty
Scand J Clin Lab Invest, 72 (1), 23-8
DOI 10.3109/00365513.2011.616220, PubMed 22149451

Burdess A, Michelsen AE, Brosstad F, Fox KA, Newby DE, Nimmo AF (2011)
Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers
Thromb Res, 129 (1), 50-5
DOI 10.1016/j.thromres.2011.08.015, PubMed 21937092

Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
Blood Purif, 32 (3), 151-5
DOI 10.1159/000325227, PubMed 21659742

Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010)
Increased YKL-40 expression in patients with carotid atherosclerosis
Atherosclerosis, 211 (2), 589-95
DOI 10.1016/j.atherosclerosis.2010.02.035, PubMed 20347092

Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
Clin Immunol, 131 (3), 438-46
DOI 10.1016/j.clim.2009.01.007, PubMed 19232508

Meen O, Brosstad F, Bjornsen S, Pedersen TM, Erikssen G (2009)
Variability in aggregometry response before and after initiation of clopidogrel therapy
Scand. J. Clin. Lab. Invest., 69 (6), PII 911832516-679
DOI 10.1080/00365510902971875

Meen Ø, Brosstad F, Bjørnsen S, Pedersen TM, Erikssen G (2009)
Variability in aggregometry response before and after initiation of clopidogrel therapy
Scand J Clin Lab Invest, 69 (6), 673-9
DOI 10.3109/00365510902971875, PubMed 19484660

Michelsen AE, Notø AT, Brodin E, Mathiesen EB, Brosstad F, Hansen JB (2008)
Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state
Thromb Res, 123 (6), 881-6
DOI 10.1016/j.thromres.2008.10.016, PubMed 19073340

Castellheim A, Thorgersen EB, Hellerud BC, Pharo A, Johansen HT, Brosstad F, Gaustad P, Brun H, Fosse E, Tønnessen TI, Nielsen EW, Mollnes TE (2008)
New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs
Scand J Immunol, 68 (1), 75-84
DOI 10.1111/j.1365-3083.2008.02122.x, PubMed 18466195

Svennevig K, Hoel T, Thiara A, Kolset S, Castelheim A, Mollnes T, Brosstad F, Fosse E, Svennevig J (2008)
Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass
Perfusion, 23 (3), 165-71
DOI 10.1177/0267659108098215, PubMed 19029267

Pytte M, Bendz B, Kramer-Johansen J, Eriksen M, Strømme TA, Eilevstjønn J, Brosstad F, Sunde K (2008)
Prearrest administration of low-molecular-weight heparin in porcine cardiac arrest: hemodynamic effects and resuscitability
Crit Care Med, 36 (3), 881-6
DOI 10.1097/CCM.0B013E318164E781, PubMed 18431276

Skjelland M, Michelsen A, Brosstad F, Svennevig JL, Brucher R, Russell D (2008)
Solid cerebral microemboli and cerebrovascular symptoms in patients with prosthetic heart valves
Stroke, 39 (4), 1159-64
DOI 10.1161/STROKEAHA.107.493031, PubMed 18292387

Meen O, Brosstad F, Khiabani H, Gjertsen E, Lauritsen ME, Pedersen TM, Bjørnsen S, Schjelderup NM, Ameln W, Ng EC, Wettergreen M, Siddique SP, Erikssen G (2008)
No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography
Scand J Clin Lab Invest, 68 (3), 185-91
DOI 10.1080/00365510701601673, PubMed 17934975

Michelsen AE, Brodin E, Brosstad F, Hansen JB (2008)
Increased level of platelet microparticles in survivors of myocardial infarction
Scand J Clin Lab Invest, 68 (5), 386-92
DOI 10.1080/00365510701794957, PubMed 18752144

Hoel TN, Videm V, Mollnes TE, Saatvedt K, Brosstad F, Fiane AE, Fosse E, Svennevig JL (2007)
Off-pump cardiac surgery abolishes complement activation
Perfusion, 22 (4), 251-6
DOI 10.1177/0267659107084142, PubMed 18181513

Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, Bakke S, Brosstad F, Damås JK, Russell D, Halvorsen B, Aukrust P (2007)
Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity
Atherosclerosis, 195 (2), e142-6
DOI 10.1016/j.atherosclerosis.2007.05.001, PubMed 17568588

Waehre T, Damås JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, Frøland SS, Semb AG, Hansteen V, Gjertsen E, Ueland T, Brosstad F, Solum NO, Aukrust P (2006)
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study
J Thromb Haemost, 4 (10), 2140-7
DOI 10.1111/j.1538-7836.2006.02131.x, PubMed 16856976

Ottestad IO, Halvorsen B, Balstad TR, Otterdal K, Borge GI, Brosstad F, Myhre AM, Ose L, Nenseter MS, Holven KB (2006)
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux
J Nutr, 136 (4), 877-81
DOI 10.1093/jn/136.4.877, PubMed 16549444

Ruud E, Holmstrøm H, Brosstad F, Wesenberg F (2006)
Children with acute lymphoblastic leukaemia have high plasma levels of total homocysteine at time of diagnosis
Scand J Clin Lab Invest, 66 (1), 67-78
DOI 10.1080/00365510500453003, PubMed 16464788

Sagedal S, Hartmann A, Osnes K, Bjørnsen S, Torremocha J, Fauchald P, Kofstad J, Brosstad F (2005)
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin
Nephrol Dial Transplant, 21 (2), 444-9
DOI 10.1093/ndt/gfi203, PubMed 16234293

Holme PA, Brosstad F, Tjønnfjord GE (2005)
Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies
Haemophilia, 11 (5), 510-5
DOI 10.1111/j.1365-2516.2005.01136.x, PubMed 16128896

Ruud E, Holmstrøm H, Brosstad F, Wesenberg F (2005)
Diagnostic value of family histories of thrombosis to identify children with thrombophilia
Pediatr Hematol Oncol, 22 (6), 453-62
DOI 10.1080/08880010591002224, PubMed 16169812

Trydal T, Bolann B, Brosstad F, Sandberg S, Sandset PM, Stavelin A, Steensland H, Thue G, Ødegaard OR (2005)
[Analysis of prothrombin time in primary health care]
Tidsskr Nor Laegeforen, 125 (15), 2048-9
PubMed 16100552

Michelsen AE, Wergeland R, Stokke O, Brosstad F (2005)
Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma
Thromb Res, 117 (6), 705-11
DOI 10.1016/j.thromres.2005.05.024, PubMed 15990159

Stormorken H, Brosstad F (2005)
[Frequent urination--an important diagnostic marker in fibromyalgia]
Tidsskr Nor Laegeforen, 125 (1), 17-9
PubMed 15643456

Mendelsohn EE, Solum NO, Brosstad F (2005)
Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test
Scand J Clin Lab Invest, 65 (4), 321-32
DOI 10.1080/00365510510025719, PubMed 16076687

Solheim BG, Flesland O, Seghatchian J, Brosstad F (2004)
Clinical implications of red blood cell and platelet storage lesions: an overview
Transfus Apher Sci, 31 (3), 185-9
DOI 10.1016/j.transci.2004.09.004, PubMed 15556465

Hoel TN, Videm V, Baksaas ST, Mollnes TE, Brosstad F, Svennevig JL (2004)
Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery
Perfusion, 19 (3), 177-84
DOI 10.1191/0267659104pf737oa, PubMed 15298426

Hognestad A, Michelsen A, Brosstad F, Damås JK, Holm T, Simonsen S, Kjekshus JK, Aukrust P, Andreassen AK (2004)
Platelet activation in heart transplant recipients
Clin Transplant, 18 (2), 142-7
DOI 10.1046/j.1399-0012.2003.00137.x, PubMed 15016127

Otterstad JE, Brosstad F (2004)
Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI
Scand Cardiovasc J, 38 (1), 9-15
DOI 10.1080/14017430310016199, PubMed 15204241

Otterstad JE, Brosstad F (2003)
Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects
Scand Cardiovasc J, 37 (6), 316-23
DOI 10.1080/14017430310015875, PubMed 14668180

Solheim BG, Flesland O, Brosstad F, Mollnes TE, Seghatchian J (2003)
Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood
Transfus Apher Sci, 29 (2), 133-9
DOI 10.1016/S1473-0502(03)00117-4, PubMed 12941351

Flom-Halvorsen HI, Øvrum E, Øystese R, Brosstad F (2003)
Quality of intraoperative autologous blood withdrawal used for retransfusion after cardiopulmonary bypass
Ann Thorac Surg, 76 (3), 744-8; discussion 748
DOI 10.1016/s0003-4975(03)00349-7, PubMed 12963190

Krohn CD, Sørensen R, Lange JE, Riise R, Bjørnsen S, Brosstad F (2003)
Tranexamic acid given into the wound reduces postoperative blood loss by half in major orthopaedic surgery
Eur J Surg Suppl (588), 57-61
PubMed 15200045

Jensenius M, Ueland T, Fournier PE, Brosstad F, Stylianou E, Vene S, Myrvang B, Raoult D, Aukrust P (2003)
Systemic inflammatory responses in African tick-bite fever
J Infect Dis, 187 (8), 1332-6
DOI 10.1086/368415, PubMed 12696016

Waehre T, Halvorsen B, Damås JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Frøland SS, Aukrust P (2002)
Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10
Eur J Clin Invest, 32 (11), 803-10
DOI 10.1046/j.1365-2362.2002.01069.x, PubMed 12423320

Noddeland H, Töllöfsrud S, Svennevig J, Bentsen G, Brosstad F, Solheim B (2002)
Universal solvent/detergent-treated fresh frozen plasma (Uniplas--rationale and clinical properties
Thromb Res, 107 Suppl 1, S33-7
DOI 10.1016/s0049-3848(02)00150-0, PubMed 12379291

Lind B, Gedde-Dahl T, Tjønnfjord G, Villoutreix BO, Brosstad F (2002)
Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation
Thromb Haemost, 88 (4), 632-8
PubMed 12362235

Flom-Halvorsen HI, Ovrum E, Brosstad F, Tangen G, Ringdal M, Oystese R (2002)
Effects of two differently heparin-coated extracorporeal circuits on markers for brain and myocardial dysfunction
Perfusion, 17 (5), 339-45
DOI 10.1191/0267659102pf594oa, PubMed 12243437

Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T (2002)
Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia
BJOG, 109 (7), 759-64
DOI 10.1111/j.1471-0528.2002.01330.x, PubMed 12135211

Sagedal S, Hartmann A, Sundstrøm K, Bjørnsen S, Brosstad F (2001)
Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets
Nephrol Dial Transplant, 16 (5), 987-93
DOI 10.1093/ndt/16.5.987, PubMed 11328905

Krohn CD, Reikerås O, Bjørnsen S, Brosstad F (2001)
Fibrinolytic activity and postoperative salvaged untreated blood for autologous transfusion in major orthopaedic surgery
Eur J Surg, 167 (3), 168-72
DOI 10.1080/110241501750099276, PubMed 11316399

Anfinsen OG, Gjesdal K, Aass H, Brosstad F, Orning OM, Amlie JP (2001)
When should heparin preferably be administered during radiofrequency catheter ablation?
Pacing Clin Electrophysiol, 24 (1), 5-12
DOI 10.1046/j.1460-9592.2001.00005.x, PubMed 11227969

Michelsen AE, Santi C, Holme R, Lord ST, Simpson-Haidaris PJ, Solum NO, Pedersen TM, Brosstad F (2000)
The charge-heterogeneity of human fibrinogen as investigated by 2D electrophoresis
Thromb Res, 100 (6), 529-35
DOI 10.1016/s0049-3848(00)00359-5, PubMed 11152933

Aukrust P, Bjørnsen S, Lunden B, Otterdal K, Ng EC, Ameln W, Ueland T, Müller F, Solum NO, Brosstad F, Frøland SS (2000)
Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy
Thromb Haemost, 84 (2), 183-7
PubMed 10959687

Holm T, Aukrust P, Andreassen AK, Ueland T, Brosstad F, Frøland SS, Simonsen S, Gullestad L (2000)
Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines
Clin Transplant, 14 (3), 218-25
DOI 10.1034/j.1399-0012.2000.140307.x, PubMed 10831080

Krohn CD, Reikerås O, Bjørnsen S, Brosstad F (2000)
Tissue factor antigen and activity in serum of postoperatively shed blood used for autologous transfusion
Blood Coagul Fibrinolysis, 11 (3), 219-23
PubMed 10870799

Roy S, Laerum F, Brosstad F, Kvernebo K, Sakariassen KS (2000)
Sequestrated thrombolysis: comparative evaluation in vivo
Cardiovasc Intervent Radiol, 23 (2), 131-7
DOI 10.1007/s002709910026, PubMed 10795838

Sandbaek G, Bjørnsen S, Sobel JH, Nieuwenhuizen W, Matsueda G, Brosstad F (2000)
Soluble fibrin species in arterial thrombi
Blood Coagul Fibrinolysis, 11 (1), 1-5
DOI 10.1097/00001721-200011010-00001, PubMed 10691094

Flom-Halvorsen HI, Ovrum E, Tangen G, Brosstad F, Ringdal MA, Oystese R (1999)
Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance
J Thorac Cardiovasc Surg, 118 (4), 610-7
DOI 10.1016/s0022-5223(99)70005-x, PubMed 10504624

Stormorken H, Brosstad F (1999)
[The "diffuse" health problems of women]
Tidsskr Nor Laegeforen, 119 (20), 3043
PubMed 10504857

Sagedal S, Hartmann A, Sundstrøm K, Bjørnsen S, Fauchald P, Brosstad F (1999)
A single dose of dalteparin effectively prevents clotting during haemodialysis
Nephrol Dial Transplant, 14 (8), 1943-7
DOI 10.1093/ndt/14.8.1943, PubMed 10462275

Roy S, Laerum F, Brosstad F, Kvernebo K, Sakariassen KS (1999)
Selective venous thrombolysis with the nipple-balloon catheter: comparative evaluation in vivo
J Vasc Interv Radiol, 10 (6), 817-24
DOI 10.1016/s1051-0443(99)70121-1, PubMed 10392954

Anfinsen OG, Gjesdal K, Brosstad F, Orning OM, Aass H, Kongsgaard E, Amlie JP (1999)
The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients
J Cardiovasc Electrophysiol, 10 (4), 503-12
DOI 10.1111/j.1540-8167.1999.tb00706.x, PubMed 10355691

Flom-Halvorsen HI, Ovrum E, Abdelnoor M, Bjørnsen S, Brosstad F (1999)
Assessment of heparin anticoagulation: comparison of two commercially available methods
Ann Thorac Surg, 67 (4), 1012-6; discussion 1016-7
DOI 10.1016/s0003-4975(99)00217-9, PubMed 10320244

Baksaas ST, Videm V, Pedersen T, Karlsen H, Mollnes TE, Brosstad F, Svennevig JL (1999)
Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices
Perfusion, 14 (2), 119-27
DOI 10.1177/026765919901400205, PubMed 10338323

Baksaas ST, Flom-Halvorsen HI, Ovrum E, Videm V, Mollnes TE, Brosstad F, Svennevig JL (1999)
Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery
Perfusion, 14 (2), 107-17
DOI 10.1177/026765919901400204, PubMed 10338322

Boberg KM, Brosstad F, Egeland T, Egge T, Schrumpf E (1999)
Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?
Thromb Haemost, 81 (3), 378-81
PubMed 10102464

Roy S, Brosstad F, Sakariassen KS (1999)
Selective thrombolysis in acute deep vein thrombosis: evaluation of adjuvant therapy in vivo
Cardiovasc Intervent Radiol, 22 (5), 403-10
DOI 10.1007/s002709900415, PubMed 10501893

Bjørtuft O, Brosstad F, Boe J (1998)
Bronchoscopy with transbronchial biopsies: measurement of bleeding volume and evaluation of the predictive value of coagulation tests
Eur Respir J, 12 (5), 1025-7
DOI 10.1183/09031936.98.12051025, PubMed 9863991

Lehne G, Nordal KP, Midtvedt K, Goggin T, Brosstad F (1998)
Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction
Thromb Haemost, 79 (6), 1119-25
PubMed 9657435

Holme PA, Solum NO, Brosstad F, Pedersen T, Kveine M (1998)
Microvesicles bind soluble fibrinogen, adhere to immobilized fibrinogen and coaggregate with platelets
Thromb Haemost, 79 (2), 389-94
PubMed 9493596

Breivik H, Brosstad F (1998)
[Bleeding complications of spinal and epidural analgesia]
Tidsskr Nor Laegeforen, 118 (2), 210-1
PubMed 9485611

Roy S, Laerum F, Brosstad F, Kvernebo K, Sakariassen KS (1998)
Animal model of acute deep vein thrombosis
Cardiovasc Intervent Radiol, 21 (4), 329-33
DOI 10.1007/s002709900270, PubMed 9688802

Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P (1998)
Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
FASEB J, 12 (1), 79-89
DOI 10.1096/fasebj.12.1.79, PubMed 9438413

Solheim BG, Bergerud UE, Kjeldsen-Kragh J, Brosstad F, Mollnes TE, Högman CF, Eriksson L, Schutz R (1998)
Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood
Vox Sang, 74 (3), 168-75
DOI 10.1046/j.1423-0410.1998.7430168.x, PubMed 9595644

Roy S, Laerum F, Brosstad F (1998)
Quantitative evaluation of selective thrombolysis techniques: influence of catheter characteristics and delivery parameters
Cathet Cardiovasc Diagn, 43 (1), 111-9
DOI 10.1002/(sici)1097-0304(199801)43:1<111::aid-ccd32>3.0.co;2-q, PubMed 9473207

Stavem P, Hovig T, Brosstad F, Holm B (1997)
[May-Hegglin's syndrome. Hereditary macrothrombocytopenia with inclusions in neutrophil granulocytes]
Tidsskr Nor Laegeforen, 117 (14), 2036-8
PubMed 9235682

Bjøro K, Blomhoff JP, Schrumpf E, Brosstad F, Bergan A, Egge T (1997)
[Hepatic vein thrombosis. Diagnostic and therapeutic difficulties]
Tidsskr Nor Laegeforen, 117 (9), 1274-6
PubMed 9182354

Brosstad F (1997)
[Control of oral anticoagulant therapy. Should the International Normalized Ratio substitute the thrombosis test?]
Tidsskr Nor Laegeforen, 117 (6), 844-5
PubMed 9102984

Sandset PM, Brosstad F (1997)
[Bleeding time indication in invasive and surgical interventions]
Tidsskr Nor Laegeforen, 117 (2), 191
PubMed 9064829

Orvim U, Barstad RM, Stormorken H, Brosstad F, Sakariassen KS (1996)
Immunologic quantification of fibrin deposition in thrombi formed in flowing native human blood
Br J Haematol, 95 (2), 389-98
DOI 10.1046/j.1365-2141.1996.d01-1892.x, PubMed 8904899

Bennick A, Haddeland U, Brosstad F (1996)
D-dimer specific monoclonal antibodies react with fibrinogen aggregates
Thromb Res, 82 (2), 169-76
DOI 10.1016/0049-3848(96)00063-1, PubMed 9163070

Haddeland U, Sletten K, Bennick A, Nieuwenhuizen W, Brosstad F (1996)
Aggregated, conformationally changed fibrinogen exposes the stimulating sites for t-PA-catalysed plasminogen activation
Thromb Haemost, 75 (2), 326-31
PubMed 8815585

Holme PA, Røsger M, Solum NO, Brosstad F, Larsen AM, Hovig T (1996)
Glycoprotein IIb-IIIa on platelet-derived microparticles, and microparticle structures studied by electron microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis
Platelets, 7 (4), 207-14
DOI 10.3109/09537109609023580, PubMed 21043689

Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M, Oystese R (1996)
Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis
Eur J Cardiothorac Surg, 10 (6), 449-55
DOI 10.1016/s1010-7940(96)80114-x, PubMed 8817142

Holme PA, Solum NO, Brosstad F, Egberg N, Lindahl TL (1995)
Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa
Thromb Haemost, 74 (6), 1533-40
PubMed 8772233

Schmidt H, Kongsgaard UE, Geiran O, Brosstad F (1995)
Autotransfusion after open heart surgery: quality of shed mediastinal blood compared to banked blood
Acta Anaesthesiol Scand, 39 (8), 1062-5
DOI 10.1111/j.1399-6576.1995.tb04230.x, PubMed 8607310

Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M (1995)
Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass
Circulation, 92 (9), 2579-84
DOI 10.1161/01.cir.92.9.2579, PubMed 7586360

Ovrum E, Holen EA, Tangen G, Brosstad F, Abdelnoor M, Ringdal MA, Oystese R, Istad R (1995)
Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects
Ann Thorac Surg, 60 (2), 365-71
DOI 10.1016/0003-4975(95)00366-s, PubMed 7646097

Holme PA, Brosstad F, Solum NO (1995)
Platelet-derived microvesicles and activated platelets express factor Xa activity
Blood Coagul Fibrinolysis, 6 (4), 302-10
DOI 10.1097/00001721-199506000-00002, PubMed 7548677

Haddeland U, Bennick A, Brosstad F (1995)
Stimulating effect on tissue-type plasminogen activator--a new and sensitive indicator of denatured fibrinogen
Thromb Res, 77 (4), 329-36
DOI 10.1016/0049-3848(95)93836-o, PubMed 7740524

Brosstad F, Buchmann M, Schilvold A (1995)
Roentgen contrast media and fibrinolysis
Acta Radiol Suppl, 399, 185-7
DOI 10.1177/0284185195036s39922, PubMed 8610513

Holme PA, Solum NO, Brosstad F, Røger M, Abdelnoor M (1994)
Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting
Thromb Haemost, 72 (5), 666-71
PubMed 7900071

Haddeland U, Bennick A, Brosstad F (1994)
Fibrinogen present in EDTA--anticoagulated plasma stimulates the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasmin
Blood Coagul Fibrinolysis, 5 (5), 767-72
DOI 10.1097/00001721-199410000-00014, PubMed 7865683

Haddeland U, Sletten K, Bennick A, Brosstad F (1994)
Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasmin
Blood Coagul Fibrinolysis, 5 (4), 575-81
PubMed 7841314

Schilvold A, Bjørnsen S, Ing C, Brosstad F (1994)
The effect of various contrast media on the activation of plasminogen by streptokinase or recombinant tissue plasminogen activator in vitro
Invest Radiol, 29 (7), 705-8
DOI 10.1097/00004424-199407000-00007, PubMed 7960617

Dale S, Gogstad GO, Brosstad F, Godal HC, Holtlund J, Mørk E, Brandsnes O, Borch SM (1994)
Comparison of three D-dimer assays for the diagnosis of DVT:ELISA, latex and an immunofiltration assay (NycoCard D-Dimer)
Thromb Haemost, 71 (3), 270-4
PubMed 8029787

Brosstad F (1993)
[Thrombin-mediated anticoagulation. The protein C/protein S/thrombomodulin system]
Tidsskr Nor Laegeforen, 113 (28), 3450-2
PubMed 8273072

Holme PA, Brosstad F, Solum NO (1993)
The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation
Thromb Haemost, 70 (4), 681-6
PubMed 8115996

Gogstad GO, Dale S, Brosstad F, Brandsnes O, Holtlund J, Mørk E, Gärtner E, Borch SM (1993)
Assay of D-dimer based on immunofiltration and staining with gold colloids
Clin Chem, 39 (10), 2070-6
PubMed 8403392

Brosstad F, Stavem P, Kofstad J, Gran T (1993)
[Diagnosis of hemoglobinopathies and thalassemias]
Tidsskr Nor Laegeforen, 113 (23), 2925-8
PubMed 8236198

Bennick A, Brosstad F (1993)
A rapid method for selecting specific hybridoma clones using paramagnetic Dynabeads
Scand J Immunol, 38 (3), 212-4
DOI 10.1111/j.1365-3083.1993.tb01716.x, PubMed 8356396

Grøn B, Filion-Myklebust C, Bjørnsen S, Haidaris P, Brosstad F (1993)
Cross-linked alpha s gamma t-chain hybrids in plasma clots studied by 1D- and 2D electrophoresis and western blotting
Thromb Haemost, 70 (3), 438-42
PubMed 8259545

Grøn B, Bennick A, Filion-Myklebust C, Brosstad F (1993)
Characterization of fibrinogen/fibrin derivatives isolated from normal and fibrinaemic plasma and serum using paramagnetic particles coated with a monoclonal antibody (mAb) to D-dimer
Blood Coagul Fibrinolysis, 4 (3), 447-54
DOI 10.1097/00001721-199306000-00009, PubMed 8329572

Kongsgaard UE, Hovig T, Brosstad F, Geiran O (1993)
Platelets in shed mediastinal blood used for postoperative autotransfusion
Acta Anaesthesiol Scand, 37 (3), 265-8
DOI 10.1111/j.1399-6576.1993.tb03713.x, PubMed 8517103

SOLHEIM BG, SVENNEVIG JL, MOHR B, DRAGSUND M, NODDELAND H, TOLLEFSRUD S, BROSSTAD F, ROLLAG H, MOLLNES TE (1993)
THE USE OF OCTAPLAS IN PATIENTS UNDERGOING OPEN-HEART-SURGERY
INT CONGR SER, 1044, 253-262

Grøn B, Filion-Myklebust C, Bennick A, Nieuwenhuizen W, Matsueda GR, Brosstad F (1992)
Early cross-linked fibrin in human plasma contains alpha-polymers with intact fibrinopeptide A
Blood Coagul Fibrinolysis, 3 (6), 731-6
DOI 10.1097/00001721-199212000-00005, PubMed 1489895

Gjønnaess E, Solum NO, Brosstad F (1992)
Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers
Blood Coagul Fibrinolysis, 3 (4), 395-405
PubMed 1420815

Grøn B, Bennick A, Filion-Myklebust C, Matsueda GR, Nieuwenhuizen W, Brosstad F (1992)
Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen
Thromb Res, 66 (2-3), 231-8
DOI 10.1016/0049-3848(92)90193-e, PubMed 1412194

Bennick A, Grøn B, Brosstad F (1991)
Hybridomas can successfully be prepared from frozen/thawn spleen cells
Hybridoma, 10 (6), 761-5
DOI 10.1089/hyb.1991.10.761, PubMed 1816075

Thorsen LI, Holm H, Reseland JE, Bjørnsen S, Hanssen LE, Brosstad F (1991)
Characterization of a human trypsin resistant to Kunitz soybean trypsin inhibitor. Studies of duodenal juices after tube instillation of raw soybean extract
Scand J Gastroenterol, 26 (6), 589-98
DOI 10.3109/00365529109043632, PubMed 1713706

Stavem P, Rørvik T, Brandtzaeg P, Brosstad F, Nordhagen R, Grabner P (1991)
Gastric lymphoma causing granulocytopenia and cold intolerance, with recovery after treatment
J Intern Med, 229 (2), 193-6
DOI 10.1111/j.1365-2796.1991.tb00330.x, PubMed 1997644

Kongsgaard UE, Tølløfsrud S, Brosstad F, Ovrum E, Bjørnskau L (1991)
Autotransfusion after open heart surgery: characteristics of shed mediastinal blood and its influence on the plasma proteases in circulating blood
Acta Anaesthesiol Scand, 35 (1), 71-6
DOI 10.1111/j.1399-6576.1991.tb03244.x, PubMed 2006603

Myrseth LE, Gulowsen AC, Davies CD, Grandaunet J, Brosstad F, Prydz H (1990)
Is the RPM cell line a useful model for the study of megakaryocyte development?
Exp Hematol, 18 (10), 1073-7
PubMed 2209761

Aakhus T, Brosstad F, Halse J, Ose L, Brodwall EK, Finne P, Natvig J, Stavem P, Heiberg A, Orstavik LA (1990)
[Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]
Tidsskr Nor Laegeforen, 110 (5), 627-8
PubMed 2309218

Grøn B, Bennick A, Nieuwenhuizen W, Brosstad F (1990)
Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A
Thromb Res, 57 (2), 259-70
DOI 10.1016/0049-3848(90)90325-7, PubMed 2315888

Grøn B, Bennick A, Nieuwenhuizen W, Bjørnsen S, Brosstad F (1988)
Immunovisualization of fibrinogen A alpha-chain heterogeneity in normal plasma and plasma from patients with DIC or on streptokinase therapy
Thromb Res, 52 (5), 413-24
DOI 10.1016/0049-3848(88)90025-4, PubMed 3222783

Thorsen LI, Gaudernack G, Hack N, Wilkinson JM, Brosstad F, Solum NO, Crawford N (1988)
Characterization of a monoclonal antibody ITI-Pl 1 directed against human platelet membrane glycoprotein IIb using extracts of whole platelets and platelet surface and intracellular membranes
Br J Haematol, 68 (1), 67-74
DOI 10.1111/j.1365-2141.1988.tb04181.x, PubMed 3278733

Thorsen LI, Holm B, Brosstad F, Solum NO (1987)
Interactions of human blood platelets with three circulating plasma fibrinogens of different molecular weights
Thromb Res, 47 (6), 683-92
DOI 10.1016/0049-3848(87)90107-1, PubMed 3686483

Thorsen LI, Hessel B, Brosstad F, Gogstad G, Solum NO (1987)
The N-DSK gamma-chain binds to immunoprecipitated GP IIb-IIIa
Thromb Res, 47 (3), 315-21
DOI 10.1016/0049-3848(87)90145-9, PubMed 3629559

Thorsen LI, Gaudernack G, Brosstad F, Pedersen TM, Solum NO (1987)
Identification of platelet antigens by monoclonal antibodies using crossed immunoelectrophoresis with immunoblotting of the monoclonal antibody
Thromb Haemost, 57 (2), 212-6
PubMed 3299855

Thorsen LI, Brosstad F, Gogstad G, Sletten K, Solum NO (1986)
Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor
Thromb Res, 44 (5), 611-23
DOI 10.1016/0049-3848(86)90163-5, PubMed 3810563

Nilsen DW, Brosstad F, Kierulf P, Godal HC (1986)
Binding of various thrombin fractions to fibrin and the influence of AT-III on their adsorption
Thromb Haemost, 55 (3), 352-6
PubMed 3750265

Thorsen LI, Brosstad F, Gogstad G, Sletten K, Solum NO (1986)
Binding of 125I-labelled fibrin(ogen) fragments to platelets and to immunoprecipitated glycoprotein IIb-IIIa complex
Thromb Res, 42 (5), 645-59
DOI 10.1016/0049-3848(86)90343-9, PubMed 2424122

Nilsen DW, Holm B, Brosstad F (1986)
Binding properties on Sepharose insolubilized fibrinogen and fibrin, of various species of fibrinogen and fibrin solubilized in plasma
Thromb Res, 42 (4), 449-59
DOI 10.1016/0049-3848(86)90208-2, PubMed 3715811

Brosstad F, Kjønniksen I, Rønning B, Stormorken H (1986)
Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies
Thromb Haemost, 55 (2), 276-8
PubMed 3520939

Thorsen LI, Brosstad F, Solum NO, Stormorken H (1986)
Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo I as compared with normal fibrinogen
Scand J Haematol, 36 (2), 203-10
DOI 10.1111/j.1600-0609.1986.tb00829.x, PubMed 3010440

Holm B, Brosstad F, Kierulf P, Godal HC (1985)
Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the a-chain is of importance for fibrin polymerization
Thromb Res, 39 (5), 595-606
DOI 10.1016/0049-3848(85)90239-7, PubMed 4082102

GODAL HC, GRAVEM K, BROSSTAD F, NYVOLD N (1985)
QUANTITATION OF FACTOR-XIII BY SDS POLYACRYLAMIDE-GEL ELECTROPHORESIS
Scand. J. Clin. Lab. Invest., 45 178, 135

Nilsen DW, Brosstad F, Holm B, Kierulf P, Godal HC (1985)
Clearance characteristics of des-AA fibrin and des-AABB fibrin, and thrombus-related uptake of des-AABB fibrin as compared to fibrinogen
Scand J Clin Lab Invest Suppl, 178, 115-9
PubMed 3867112

Teige B, Gogstad G, Brosstad F, Olaisen B (1985)
Common structural genes for platelet and plasma fibrinogen
Blood, 65 (1), 120-6
PubMed 3965044

NILSEN DWT, BROSSTAD F, HOLM B, KIERULF P, GODAL HC (1985)
CLEARANCE CHARACTERISTICS OF DES-AA FIBRIN AND DES-AABB FIBRIN, AND THROMBUS-RELATED UPTAKE OF DES-AABB FIBRIN AS COMPARED TO FIBRINOGEN
Scand. J. Clin. Lab. Invest., 45 178, 115-119

Godal HC, Gravem K, Brosstad F, Nyvold N (1984)
Quantitation of factor XIII by SDS polyacrylamide gel electrophoresis
Thromb Res, 35 (5), 577-82
DOI 10.1016/0049-3848(84)90289-5, PubMed 6484899

Nilsen DW, Brosstad F, Holm B, Kierulf P, Gravem K, Godal HC (1984)
Thrombus-related uptake and vascular clearance of 131 I-fibrin des-AABB as compared to 125 I-fibrinogen in patients with established venous thrombosis
Thromb Haemost, 51 (2), 165-8
PubMed 6740548

Brath HK, Madsbu HP, Brosstad F (1983)
[Felden (piroxicam) in arthroses. A post-marketing study]
Tidsskr Nor Laegeforen, 103 (26), 1827-30
PubMed 6359580

Hagen I, Gogstad GO, Brosstad F, Solum NO (1983)
Demonstration of 125I-labelled thrombin binding platelet proteins by use of crossed immunoelectrophoresis and autoradiography
Biochim Biophys Acta, 732 (3), 600-6
DOI 10.1016/0005-2736(83)90237-7, PubMed 6307375

Gogstad GO, Brosstad F (1983)
Complex-formation between the fibrin-derived plasmic fragments DD and E demonstrated by crossed immunoelectrophoresis
Thromb Res, 30 (5), 441-8
DOI 10.1016/0049-3848(83)90178-0, PubMed 6225217

Stormorken H, Brosstad F, Seim H (1983)
A new dysfibrinogenemia: fibrinogen Oslo IV
Thromb Haemost, 49 (2), 120-2
PubMed 6868008

Solum NO, Olsen TM, Gogstad GO, Hagen I, Brosstad F (1983)
Demonstration of a new glycoprotein Ib-related component in platelet extracts prepared in the presence of leupeptin
Biochim Biophys Acta, 729 (1), 53-61
DOI 10.1016/0005-2736(83)90455-8, PubMed 6219704

HAMBORG T, SKJENNALD A, GODAL HC, BROSSTAD F (1983)
SOLUBLE FIBRIN (ETHANOL GELATION TEST) AND FIBRIN(OGEN) DEGRADATION PRODUCTS IN SUSPECTED THROMBOSIS WITH REFERENCE TO THE I-125-LABELED FIBRINOGEN UPTAKE TEST FOR DETECTION OF THROMBUS FORMATION
SCAND J HAEMATOL, 30 39, 65-74

Conard J, Brosstad F, Lie Larsen M, Samama M, Abildgaard U (1983)
Molar antithrombin concentration in normal human plasma
Haemostasis, 13 (6), 363-8
DOI 10.1159/000214823, PubMed 6667903

KIERULF P, BROSSTAD F, ANDERSEN AB (1983)
FSF-STABILIZED SOLUBLE FIBRINOGEN FIBRIN INTERMEDIATES IN CA++-PLASMA AT 37-DEGREES-C
SCAND J HAEMATOL, 30 39, 97-102

HOLM B, BROSSTAD F, GODAL HC (1983)
HEPARIN PRECIPITABLE FRACTION OF PLASMA (HPF) IS NOT INFLUENCED BY THE PRESENCE OF FIBRIN MONOMERS
SCAND J HAEMATOL, 30 39, 75-80

BROSSTAD F, ELDE AT, GODAL HC (1983)
LYOPHILIZED, RECONSTITUTED PLASMA AS SUBSTRATE FOR THROMBIN ACTIVITY ASSAYS
SCAND J HAEMATOL, 30 39, 87-89

BJORNSON J, RYGH M, BROSSTAD F (1983)
NORMALIZATION OF FIBRIN INDUCED PLATELET-AGGREGATION IN UREMIC PATIENTS UNDERGOING HEMODIALYSIS
SCAND J HAEMATOL, 30 39, 33-38

BROSSTAD F, KIERULF P (1983)
SOLUBLE I-131 FIBRIN FORM HIGH MOLECULAR-WEIGHT COMPLEXES IN PROTHROMBIN-DEPLETED, RECALCIFIED PLASMA AT +37-DEGREES-C
SCAND J HAEMATOL, 30 39, 91-95

Gogstad GO, Brosstad F, Krutnes MB, Hagen I, Solum NO (1982)
Fibrinogen-binding properties of the human platelet glycoprotein IIb-=IIIa complex: a study using crossed-radioimmunoelectrophoresis
Blood, 60 (3), 663-71
PubMed 6286013

Hagen I, Brosstad F, Gogstad GO, Korsmo R, Solum NO (1982)
Further studies on the interaction between thrombin and GP Ib using crossed immunoelectrophoresis. Effect of thrombin inhibitors
Thromb Res, 27 (5), 549-54
DOI 10.1016/0049-3848(82)90301-2, PubMed 6294899

Galdal KS, Evensen SA, Brosstad F (1982)
Effects of thrombin on the integrity of monolayers of cultured human endothelial cells
Thromb Res, 27 (5), 575-84
DOI 10.1016/0049-3848(82)90304-8, PubMed 7179206

Hagen I, Brosstad F, Gogstad GO, Solum NO, Korsmo R (1982)
Demonstration of variable forms of the platelet factor 4 immunoprecipitate using crossed immunoelectrophoresis
Thromb Res, 27 (1), 77-82
DOI 10.1016/0049-3848(82)90280-8, PubMed 6812236

Hagen I, Brosstad F, Solum NO, Korsmo R (1981)
Crossed immunoelectrophoresis using immobilized thrombin in intermediate gel. A method for demonstration of thrombin-binding platelet proteins
J Lab Clin Med, 97 (2), 213-20
PubMed 7452092

Godal HC, Elde AT, Nyborg N, Brosstad F (1980)
The normal range of osmotic fragility of red blood cells
Scand J Haematol, 25 (2), 107-12
DOI 10.1111/j.1600-0609.1981.tb01374.x, PubMed 7466299

Brosstad F, Rygh M, Kierulf P, Godal HC, Eika C (1980)
Interaction of platelets with soluble, polymerizing and polymerized des-AA and des-AABB fibrin in human plasma
Thromb Res, 18 (1-2), 123-30
DOI 10.1016/0049-3848(80)90176-0, PubMed 6447384

Andersen P, Andersen S, Brosstad F (1980)
Reduced antiheparin effect of desialyzed alpha 1-acid glycoprotein
Thromb Res, 17 (6), 865-71
DOI 10.1016/0049-3848(80)90251-0, PubMed 7404492

Brosstad F, Kierulf P, Godal HC (1979)
The fibrin-solubilizing effect of fibrinogen as studied by light scattering
Thromb Res, 14 (4-5), 705-12
DOI 10.1016/0049-3848(79)90126-9, PubMed 483265

Kierulf P, Brosstad F, Godal HC, Lund PK, Andersen AB, Naeverlid I (1979)
Poor discriminating power of fibrinogen-sepharose towards plasma fibrinogen, fibrin des-AA and fibrin des-AABB monomers, as studied by labelled proteins, laser nephelometric FR-antigen and RIA-FPA quantitation
Thromb Res, 16 (1-2), 1-10
DOI 10.1016/0049-3848(79)90264-0, PubMed 505413

Brosstad F (1979)
Fibrinolysis of soluble and polymerized des-AA/des-AABB fibrin compared to fibrinogenolysis in buffer and in fibrinogen-boosted serum. Evidence that plasminogen activators are responsible for preferential degradation of polymerized fibrin
Thromb Res, 15 (3-4), 497-504
DOI 10.1016/0049-3848(79)90155-5, PubMed 158847

Brosstad F, Kierulf P, Gravem K, Godal HC (1978)
Purification and insolubilization of reptilase for the preparation of human des-AA fibrin monomers in urea
Thromb Res, 13 (5), 715-23
DOI 10.1016/0049-3848(78)90177-9, PubMed 741447

Brosstad F (1978)
Lower susceptibility of human des-AA versus des-AABB fibrin towards fibrin stabilizing factor
Thromb Res, 13 (5), 799-803
DOI 10.1016/0049-3848(78)90184-6, PubMed 741452

Godal HC, Brosstad F, Kierulf P (1978)
Three new cases of an inborn qualitative fibrinogen defect (fibrinogen Oslo II)
Scand J Haematol, 20 (1), 57-62
DOI 10.1111/j.1600-0609.1978.tb01554.x, PubMed 75566

GODAL HC, BROSSTAD F, KIERULF P (1978)
3 NEW CASES OF AN INBORN QUALITATIVE FIBRINOGEN DEFECT (FIBRINOGEN OSLO-II)
SCAND J HAEMATOL, 20 (1), 57-62

Bjørnson J, Brosstad F (1978)
Platelet and fibrin(ogen) deposition in the artificial kidney. The influence of haematocrit, fibrin monomer and platelet inhibitors. An in vitro study
Scand J Urol Nephrol, 12 (3), 259-64
DOI 10.3109/00365597809179727, PubMed 725548

Brosstad F (1977)
Purification, characterization and insolubilization of bovine thrombin
Thromb Res, 11 (2), 119-30
DOI 10.1016/0049-3848(77)90030-5, PubMed 20675

Brosstad F, Godal HC (1977)
Qualitative changes in fibrinogen following exposure to agents used for preparation of fibrin monomers
Haemostasis, 6 (3), 149-56
DOI 10.1159/000214174, PubMed 18381

Brosstad F, Godal HC, Kierulf P (1977)
Some characteristics of various fibrin monomer preparations made from dissolved fibrin clots
Haemostasis, 6 (4), 213-24
DOI 10.1159/000214183, PubMed 914080

Brosstad F, Godal HC, Kierulf P (1977)
Preparation of fibrin monomers from human fibrinogen in urea, using soluble or insolubilized thrombin
Haemostasis, 6 (4), 225-35
DOI 10.1159/000214184, PubMed 914081

Godal HC, Brosstad F, Kierulf P (1977)
The ethanol gelation test and thrombosis
Bibl Haematol, 44, 156-60
DOI 10.1159/000402167, PubMed 617779

Godal HC, Brosstad F, Kierulf P (1977)
Influence of NA2-EDTA and some compounds used for dissolution of fibrin clots on the physiochemical properties of fibrinogen and fibrin
Bibl Haematol, 44, 151-5
DOI 10.1159/000402166, PubMed 104706

Petersen H, Brosstad F (1977)
Pattern of acute drug poisoning in Oslo
Acta Med Scand, 201 (3), 233-7
DOI 10.1111/j.0954-6820.1977.tb15689.x, PubMed 848364

Petersen H, Brosstad F (1974)
[Tendencies in the poisoning pattern]
Tidsskr Nor Laegeforen, 94 (25), 1543
PubMed 4418841

Review articles

Sandbaek G, Bjørnsen S, Brosstad F (1999)
Catheter-directed intra-arterial thrombolysis: size of soluble fibrin(ogen) degradation products studied by electrophoresis and immunoblotting
Blood Coagul Fibrinolysis, 10 (4), 189-95
DOI 10.1097/00001721-199906000-00005, PubMed 10390118

Krohn CD, Reikerås O, Bjørnsen S, Brosstad F (1999)
Fibrinogen, fibrin and its degradation products in drained blood after major orthopaedic surgery
Blood Coagul Fibrinolysis, 10 (4), 167-71
DOI 10.1097/00001721-199906000-00002, PubMed 10390115

Sandbaek G, Bjørnsen S, Brosstad F (1999)
Soluble, thrombin-related material in arterial thrombi and plasma studied during catheter-directed intra-arterial thrombolysis
Blood Coagul Fibrinolysis, 10 (2), 87-91
DOI 10.1097/00001721-199903000-00005, PubMed 10192657

Brosstad F (1993)
[Von Willebrand's disease--gene, molecule, clinical findings, treatment]
Tidsskr Nor Laegeforen, 113 (23), 2894-8
PubMed 8236189

Other articles

Solum NO, Brosstad F, Østerud B, Sakariassen KS, Gogstad G (2019)
Professor Helge Stormorken, 1922-2019
J Thromb Haemost, 17 (9), 1579-1580
DOI 10.1111/jth.14585, PubMed 31479185

Stormorken H, Brosstad F (2005)
[Overactive bladder syndrome]
Tidsskr Nor Laegeforen, 125 (21), 2997
PubMed 16276393

Blomhoff S, Holven KB, Brosstad F, Ose L, Nenseter MS (2004)
Psychological factors and cardiovascular disease
J Thromb Haemost, 2 (1), 201-3
DOI 10.1111/j.1538-7836.2004.0562g.x, PubMed 14717990

Ruud E, Holmstrøm H, Aagenaes I, Hafsahl G, Handeland M, Kyte A, Brosstad F (2003)
Successful thrombolysis by prolonged low-dose alteplase in catheter-directed infusion
Acta Paediatr, 92 (8), 973-6
DOI 10.1080/08035250310004270, PubMed 12948076

Solheim BG, Bergan A, Brosstad F, Innes R, Svennevig JL (2003)
Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas)
Anesth Analg, 96 (4), 1230-1231
DOI 10.1213/01.ANE.0000044044.61979.74, PubMed 12651690

Asselta R, Tenchini ML, Holme R, Brosstad F, Stormorken H (2003)
The discovery of Mary's mutation
J Thromb Haemost, 1 (2), 397-8
DOI 10.1046/j.1538-7836.2003.00151.x, PubMed 12871526

Brennan SO, Ridgway H, Stormorken H, Brosstad F, George PM (1997)
Characterisation of Fibrinogen Oslo IV by electrospray mass spectrometry
Thromb Haemost, 77 (5), 1040-1
PubMed 9184429

Stavem P, Brosstad F (1996)
[The Vacouver rules--common sense and civil manners]
Tidsskr Nor Laegeforen, 116 (10), 1259
PubMed 8658404

Stavem P, Brinch L, Brosstad F (1996)
[On co-authors and pathologists]
Tidsskr Nor Laegeforen, 116 (1), 110-1
PubMed 8553318

Tjønnfjord GE, Brosstad F (1993)
[Treatment (and diagnosis) of menorrhagia]
Tidsskr Nor Laegeforen, 113 (27), 3383-4
PubMed 8273068

Stormorken H, Brosstad F (1992)
Fibromyalgia: family clustering and sensory urgency with early onset indicate genetic predisposition and thus a "true" disease
Scand J Rheumatol, 21 (4), 207
DOI 10.3109/03009749209099225, PubMed 1529291

Tjønnfjord GE, Evensen SA, Brosstad F, Glomstein A, Solheim B (1991)
[Treatment of von Willebrand's disease with coagulation factor concentrates]
Tidsskr Nor Laegeforen, 111 (15), 1886
PubMed 1853330

Tjønnfiord G, Stavem P, Brosstad F, Stormorken H (1989)
[Use of Octa V.I. in patients with severe hemophilia]
Tidsskr Nor Laegeforen, 109 (19-21), 2053-4
PubMed 2501908

Nilsen DW, Brosstad F (1986)
Discrepant elimination of fibrin des-AA and des-AABB in man
Thromb Haemost, 55 (3), 439
PubMed 3750275

Gogstad GO, Brosstad F (1983)
Platelet factor XIII is an active enzyme after solubilization and crossed immunoelectrophoresis
Thromb Res, 29 (2), 237-41
DOI 10.1016/0049-3848(83)90145-7, PubMed 6845278

STORMORKEN H, GOGSTAD GO, BROSSTAD F (1983)
HEREDITARY ALPHA-2-ANTIPLASMIN DEFICIENCY
Thromb. Res., 31 (4), 647-651
DOI 10.1016/0049-3848(83)90462-0

Brosstad F, Kierulf P, Gravem K, Godal HC (1979)
Cryoprecipitation- a more efficient method than agarose gel chromatography for removal of contaminating soluble fibrin in human fibrinogen preparations
Thromb Res, 16 (1-2), 275-8
DOI 10.1016/0049-3848(79)90290-1, PubMed 41338

Brosstad F, Godal HC (1979)
Incomplete transformation of plasma fibrinogen to fibrin. Fibrinogen content and streptokinase-induced intra-clot lysis susceptibility of des-AA or des-AABB fibrin clots formed at varying fibrinogen/fibrin ratios
Thromb Res, 14 (2-3), 507-12
DOI 10.1016/0049-3848(79)90259-7, PubMed 442019

Brosstad F (1979)
Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes
Thromb Res, 15 (3-4), 563-8
DOI 10.1016/0049-3848(79)90163-4, PubMed 40318

Lund PK, Brosstad F, Kierulf P (1977)
Detection of soluble fibrin in plasma using fibrinogen sepharose columns
Thromb Res, 11 (6), 907-12
DOI 10.1016/0049-3848(77)90119-0, PubMed 601758

Books

Brosstad F, Brosstad F, Brinch L (2005)
Arteriell og venøs tromboembolisme, profylakse og behandling: veileder for profylakse og behandling av arteriell og venøs tromboembolisme ved Rikshospitalet
Rikshospitalet, [Oslo], 94, 95-107 s.
BIBSYS 051344203, ISBN 82-92311-02-5

Brosstad F, Laake K, Barkvoll P (2002)
Propedeutisk kurs i klinisk undersøkelsesmetodikk og journalskriving for OD-stud.: en orientering for lærere og studenter til bruk i 3. semester
Unipub, Oslo, 24 s.
BIBSYS 020222343

Brosstad F (2001)
Arteriell og venøs tromboembolisme: profylakse og behandling
Rikshospitalet, [Oslo], 44 s.
BIBSYS 030712114, ISBN 82-992440-2-1

Brosstad F (1999)
Fragmin, standard heparin og marevan i profylakse og behandling
Rikshospitalet, [Oslo] (Ny utg.), 44 s.
BIBSYS 000668567, ISBN 82-994508-1-0

Brosstad F (1997)
Klinisk undersøkelsesmetodikk og journalskriving: en orientering for lærere og studenter til bruk i 3. semester
Unipub, Oslo (rev.1997), 20 s.
BIBSYS 02022270x

Brosstad F (1990)
Hemostase: blødning, trombose, emboli
Nycomed Pharma, Oslo, 83 s.
BIBSYS 04058402x

Brosstad F (1980)
Studies on human des-AA and des-AABB fibrin monomers: with special reference to preparation and characterization, and to their interaction with fibrinogen, FSF, plasmin andplatelets in vitro
[The Author], Oslo, 1 b.(fl.pag.)
BIBSYS 822019647

Book chapters

Otterstad JE, Brosstad F (2007)
Utviklingen av den medisinske behandlingen av hjertepasienter
In Det Norske hjerte: norsk hjertemedisins historie, Universitetsforl., Oslo, s. 193-205
BIBSYS 070830304

Jensenius M, Ueland T, Fournier PE, Brosstad F, Stylianou E, Vene S, Myrvang B, Raoult D, Aukrust P (2003)
Systematic inflammatory responses in African tick-bite fever
In Journal of infectious diseases, University of Chicago Press, Chicago, 187(2003)8, s.1332-6
BIBSYS 041718305